SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-244443
Filing Date
2011-09-09
Accepted
2011-09-09 15:03:40
Documents
6
Period of Report
2011-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 14376
2 SECOND AMENDMENT TO CREDIT AGREEMENT dex10a.htm EX-10.(A) 26113
3 LINE OF CREDIT NOTE (FACILITY A) dex10b.htm EX-10.(B) 19985
4 LINE OF CREDIT NOTE (FACILITY B) dex10c.htm EX-10.(C) 18239
5 GRAPHIC g230533ex10bpg1.jpg GRAPHIC 7018
6 GRAPHIC g230533ex10cpg1.jpg GRAPHIC 7018
  Complete submission text file 0001193125-11-244443.txt   99569
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 111083304
SIC: 2835 In Vitro & In Vivo Diagnostic Substances